CapLaw-2020-06

  • Acquisition of The Medicines Company

    In connection with the acquisition of NASDAQ-listed biopharmaceutical company The Medicines Company for USD 9.7 billion, Novartis AG and Novartis Finance Corporation entered into a USD 7 billion short-term (bridge) credit agreement and completed a USD 5 billion four-tranche SEC-registered bond offering.

    By

    CapLaw

    Reference:
    Read more: Acquisition of The Medicines Company